Santiago Montes Moreno

Santiago Montes Moreno (Madrid, July 11, 1977) was graduated in Medicine by the Universidad Autonoma de Madrid (2002) and made his residency in Anatomic Pathology in the Hospital Universitario 12 de Octubre, Madrid. After that he stayed during 5 years in the Lymphoma Group, Molecular Pathology Department at CNIO (Centro Nacional de Investigaciones Oncologicas) where he was trained in Hematopathology, Molecular Diagnosis and Research. He joined several research projects in the field of lymphoma molecular pathology and published a number of papers in high impact journals. He obtained his PhD degree by the Universidad de Cantabria in 2015, with a thesis entitled Identification of Diagnostic and Prognostic Markers in Aggressive Large B Cell Lymphoma (Cum Laude, Premio Extraordinario de Doctorado).

During the first semester of 2016 he had a position as visiting scientist in MD Anderson Cancer Centre, Houston, USA, granted by the Instituto de Salud Carlos iii (MBAE BA15/0053). He had a collaboration with the Molecular Diagnostics Unit of the Hematopathology Department and was trained in the application of new technologies to the molecular diagnosis of hematolymphopid neoplasms.

Now Santiago has a position as staff pathologist with dedication to hematopathology and soft tissue pathology and routine molecular diagnosis in hematopathology and sarcoma (Pathology department, HUMV). He is also assistant professor in the Universidad de Cantabria since 2015. 

Santiago is group leader of the emerging group TRANSLATIONAL HEMATOPATHOLOGY in IDIVAL since March 1, 2018.

Research focus:

Santiago´s research activity is focused in the identification of biological markers with diagnostic and prognostic utility, mainly in B cell lymphoma. For that purpose he is working on the integration of molecular data (gene expression and protein expression profiles, microRNA expression profiles and mutational profiles) with data related to clinical diagnosis and follow up of patients enrolled in different clinical trials.

Santiago is the Principal Investigator of a national competitive Project funded by MINECO (PI16/1397) entitled Targeted exonic next generation sequencing for the molecular diagnosis and cell free tumor DNA analysis as screening method for patients with DLBCL that has allowed our group to set up a platform for the genotyping of DLBCL patient samples from clinical trials using liquid biopsy (ctDNA). We also validate tools for the molecular diagnosis of lymphoid neoplasms (i.e MYD88 L265P somatic mutation) and perform the centralized histopathological review of patient samples included in large B cell lymphoma trials from the GELTAMO Group.

Active collaborations and Professional Society Memberships.

Santiago has active collaborations with the Euroclonality/Biomed 2 group and the GELTAMO Group. He is the coordinator of the Spanish Lymphoma Club of the Spanish Society of Anatomic Pathology, and officer of the Executive Comitee of the European Association of Hematopathology (EAHP). The Traslational Hematopathology Group-IDIVAL is member of the CIBERONC in the Lymphoma Group.

ORCID ID: orcid.org/0000-0002-3565-8262